Symrise expands France production as Symrise stock sits 0.49 percent below its yearly high

Symrise (ISIN DE000SYM9999) is expanding production in France, while its stock sits 0.49 percent below the 52-week high at a substitute Xetra price of EUR 102.35 on October 26, 2026 at 12:07 p.m. CEST. According to the Symrise investor page, the company reported the France expansion on October 22, 2026.

Production expansion adds a concrete catalyst

The France project extends Symrise's Taste, Nutrition and Health activities and supports its global customer base. The company operates at more than 100 locations and serves more than 6,000 global, regional and local customers, according to the Symrise investor page.

The operating backdrop is measurable in the company's historical financial base. Symrise generated EUR 4.929 billion of revenue and an organic growth rate of 2.80 percent in fiscal year 2025, while its EBITDA margin was 21.90 percent excluding the impairment of its associate Swedencare, the company reported.

What does the EUR 99 target signal?

Bernstein analyst James Hooper kept a Market-Perform rating and a EUR 99.00 price target on October 20, 2026, according to FinanzNachrichten. The target is EUR 3.35 below the substitute Xetra price, a 3.27 percent gap that leaves valuation and execution as the key counterweights to the production expansion.

Three recent milestones shape the setup

On October 15, 2026, Symrise expanded its Globalide fragrance ingredient production platform in India, according to Finanzen.at. On October 20, Bernstein maintained its EUR 99.00 target. On October 22, Symrise reported the France production expansion. The sequence links capacity investment with an approaching test of organic growth.

Next reporting date

Symrise's next scheduled event is the third-quarter 2026 interim update on October 28, 2026. The same date is listed for a virtual management roadshow on the company's investor-relations page. Those dates give investors a near-term reference for judging whether capacity investment is translating into growth.

Stock stays near its yearly high

The substitute price from Xetra stood at EUR 102.35 on October 26, 2026 at 12:07 p.m. CEST, 0.34 percent above the Xetra close of October 23, 2026 at EUR 102.00. The 52-week range was EUR 64.70 to EUR 102.85 as of October 26, 2026, placing the quote EUR 0.50 below the high.

Market context: Market report DAX.

More news and analyses on Symrise stock